Alabama

Alabama

NO
Registered Patient Population
0%
of Total Population Represented by Patients
N/A
Average Price Per 1/8
N/A
Average Price Per Gram Cannabis Oil
0
Total Medical Retail Locations Currently in Operation
N/A
Ratio of Patients to Retail Location

Only CBD is legal in Alabama; their CBD laws conform to USDA regulations from the 2018 Farm Bill. Patients report limited availability.

Patient Rights and Civil Protection 23/100   
Arrest Protection 0/40
Affirmative Defense 10/15
Parental Rights Protections 8/10
DUI Protections 0/5
Employment Protections 0/5
Explicit Privacy Standards 0/7
Housing Protections 0/5
Does Not Create New Criminal Penalties for Patients 5/5
Organ Transplants 0/5
Reciprocity 0/3
Access to Medicine 13/100   
Allows Distribution Programs 0/40
– Allows Access to Dried Flowers 0/15
– Allows Delivery 0/5
– No Sales Tax or Reasonable Sales Tax 0/5
– Allows for a Reasonable Number of Dispensaries 0/5
– Does Not Require Vertical Integration 0/2
– Ownership/Employment Restrictions 0/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 0/2
Noncommercial Cultivation 0/20
– Personal Cultivation 0/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 0/10
Does Not Impose Bans or Limits on THC 3/10
Does Not Impose Bans on CBD 10/10
Local Bans/Zoning 0/10
Comprehensive Qualifying Conditions 35/50
Adding New Conditions 0/10
– Law/Regulations Allow for New Conditions 0/5
– System Works for Adding New Conditions 0/5
Reasonable Access for Minors 8/10
Reasonable Caregiver Background Checks 4/4
Number of Caregivers 2/2
Patient/Practitioner-Focused Task Force or Advisory Board 2/2
Reasonable Fees (Patients and Caregivers) 7/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 5/5
Does Not Classify Cannabis as a Medicine of Last Resort 5/5
Functionality 35/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 5/50
No Significant Administrative or Supply Problems 10/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 10/10
Reasonable Possession Limits 5/5
Reasonable Purchase Limits 0/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 2/7
Consumer Safety and Provider Requirements 0/100   
Dispensing 0/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility Sanitary Conditions 0/1.25
– Storage Protocols 0/1.25
– Reasonable Security Protocols 0/1.25
– Inventory Control 0/1.25
Recall Protocol and Adverse Event Reporting 0/5
Product Labeling 0/5
– Product Contents, Including Source Material Identification 0/1.67
– Allergens 0/1.67
– Potency/Compound Identification 0/1.67
Required Testing 0/5
– Active Compound Identification 0/1.67
– Contaminants 0/1.67
– Potency 0/1.67
Grow/Cultivation 0/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0/0.71
– Reasonable Security Protocols 0/0.71
– Batch and Lot Tracking 0/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 0/5
– Pesticide Guidance 0/2.5
– Pesticide Labeling 0/2.5
Required Testing 0/5
– Active Ingredient Identification 0/1.25
– Contaminants 0/1.25
– Potency 0/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 0/5
Manufacturing 0/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/1
– Workforce Safety Protocols 0/1
– Storage Protocols 0/1
– Reasonable Security Protocols 0/1
– Batch and Lot Tracking 0/1
Product Labeling 0/5
– Product Contents, Including Source Material Identification 0/1.67
– Allergens 0/1.67
– Potency and Compound Information 0/1.67
Required Testing 0/5
– Active Ingredient Identification 0/1
– Contaminants 0/1
– Potency 0/1
– Shelf Life Testing 0/1
– Sample Retention 0/1
Recall Protocol and Adverse Event Reporting 0/5
Laboratory Operations 0/25
Staff Training 0/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 0/5
Independent or Third Party 0/5
Standard Operating Procedures and Protocols 0/5
– Equipment and Instrument Calibration 0/0.83
– Sample Tracking 0/0.83
– Facility and Equipment Sanitary Conditions 0/0.83
– Disposal/Waste 0/0.83
– Storage Protocols 0/0.83
– Workforce Safety Protocols 0/0.83
Covid Response 0/20   
Delivery Available? 0/6
Curbside Pickup Available? 0/2
Medical Cannabis Essential? 0/7
Telemedicine Available? 0/5
Excerpted from ASA's 2020 State of the States Report.

In This Section

Alabama Medical Marijuana Laws and Regulations

In 2014, the Alabama state legislature passed SB 174, a restrictive cannabidiol (CBD) law. Officially entitled "Carly's Law," it offers an affirmative defense for the possession and use of CBD. HB61 (2016) extends low-THC extract affirmative defense to patients with more qualifying conditions as well as parent caregivers.

Becoming a Patient in Alabama

To become a patient eligible for CBD under Leni’s Law, the patient must receive a diagnosis for a serious condition that is resistant to conventional medicine from, and be provided CBD by, a physician with whom they have a bona-fide physician-patient relationship and the CBD must be likely to provide the patient with therapeutic or palliative relief.

Recommending Cannabis in Alabama

Under Leni’s Law, physicians with a bona fide physician-patient relationship to the patient may recommend CBD, but a recommendation is not required. This would allow physicians who otherwise treat a patient to prescribe CBD to such patient but is designed to exclude one-off engagements for the purposes of providing CBD from protection under the law.

Becoming a Caregiver, Producer, or Provider in Alabama

Carly’s Law previously provided a protection for caretakers of patients, but this was deleted under the Leni’s Law amendments.

The State of Medical Marijuana in Alabama

The State of Medical Marijuana in Alabama